Naloxone hydrochloride sublingual tablets

Pharmacology: This product is an opioid receptor specific antagonist, and has antagonistic effects on four opioid receptor subtypes (μ-receptor, δ-receptor, κ-receptor, б-receptor). For morphine poisoning, a small dose (0.4-0.8 mg) of intramuscular or intravenous injection can quickly reverse the effects of morphine, and eliminate the respiratory depression, sedation, pupil constriction caused by morphine poisoning, and the effects of lowering blood pressure and coma caused by severe poisoning in 1-3 minutes. It can quickly induce withdrawal syndrome in morphine addicts. Naloxone also has an anti-shock effect, which counteracts the effect of endorphins during shock. It has a wake-up effect on alcohol poisoning animals.

This product is white tablets.

It is used for acute alcohol poisoning, limited to the intoxication state of acute alcohol poisoning with unstable gait, excessive talk, incoherence, euphoria, ataxia, slow perception, drowsiness, and lethargy, but not accompanied by coma and changes in vital signs. The main ingredients and chemical names of this product are: 17-allyl-4,5; epoxy-3,14-hydroxymorphinan-6-one hydrochloride dihydrate. The basic structural formula is: Molecular formula: C19H21NO4; HCl; 2H2O Molecular weight: 399.87.

Take orally, 0.4-0.8 mg per time

This product causes mild drowsiness, and occasionally nausea, vomiting, tachycardia, hypertension and irritability.

This product is a pregnancy risk class C drug, so pregnant and lactating women should use it with caution.

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: This product is a pregnancy risk class C drug, so pregnant and lactating women should be particularly cautious when using this product. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

Naloxone promotes the absorption of ethanol from the gastrointestinal tract, so ethanol should not be used after oral administration of this product.

Keep in dark, airtight and cool place.

0.4 mg

36 months

Beijing Wellso Pharmaceutical Co., Ltd.

• Founded in:

  2000-06-28

• Address:

  No. 1, Jinguang North Street, Liangxiang Town Industrial Development Zone, Fangshan District, Beijing

• Tax NO.:

  911100007226097157

• Registered Funds:

  105.6005 million yuan

• Website:

  Log in to view

• Email:

  Log in to view